Daewoong Pharmaceutical and Medytox focusing on taking superiority in global market aside from the legal suit

Having conflicts over the botulinum toxin strain issue, Daewoong Pharmaceutical and Medytox are going on a new direction.

Thinking ‘taking a step backward is losing; so far, they have taken a ‘truth or dare’ game with the ‘legal war’ which revealed their weak points, but both of them have now started to draw the ‘big picture.’

Of course, they are still working on the legal war, but in the cir...